Food banks nationwide are being pinched by record demand, high food prices, and hundreds of millions of dollars in federal budget cuts.

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

HealthDay News — The US Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced a new initiative called “Generation Gold Standard” to develop ...

No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, and stroke.

"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary.

There is a difference between the terms "tardive dyskinesia" and "tardive syndrome" that clinicians should be aware of when providing care.

Researchers conducted a retrospective and prospective observational study to assess the effect of denosumab plus romosozumab on severe postmenopausal osteoporosis.